Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation.

Inamoto, Y; Nishida, T; Suzuki, R; Miyamura, K; Sao, H; Iida, H; Naoe, T; Maruyama, F; Hirabayashi, N; Hamaguchi, M; Iseki, T; Kami, M; Yano, K; Takeyama, H; Morishita, Y; Morishima, Y; Kodera, Y

Inamoto, Y; Nishida, T; Suzuki, R; Miyamura, K; Sao, H; Iida, H; Naoe, T; Maruyama, F; Hirabayashi, N; Hamaguchi, M; Iseki, T; Kami, M; Yano, K; Takeyama, H; Morishita, Y; Morishima, Y; Kodera, Y.

Affiliation

Inamoto Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. yinamoto@js3.so-net.ne.jp

Bone Marrow Transplant ; 39(1): 25-30, 2007 Jan.

Article in En | MEDLINE | ID: mdl-17115063

Subject(s)

Cyclophosphamide/administration & dosage; Cytarabine/administration & dosage; Graft vs Host Disease/mortality; Immunosuppressive Agents/administration & dosage; Myeloablative Agonists/administration & dosage; Stem Cell Transplantation/mortality; Transplantation Conditioning; Adolescent; Adult; Chronic Disease; Disease-Free Survival; Female; Graft vs Host Disease/etiology; Hematologic Neoplasms/mortality; Hematologic Neoplasms/therapy; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Rate; Tissue Donors; Transplantation, Homologous; Whole-Body Irradiation

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Transplantation Conditioning / Myeloablative Agonists / Cyclophosphamide / Cytarabine / Stem Cell Transplantation / Graft vs Host Disease / Immunosuppressive Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Year: 2007 Type: Article

Search on Google

XML

PubMed Links